Abstract 292: Validation of a Peripheral Blood Mononuclear Cell Gene Expression Network. A Systems Biological Approach to the Identification of Immunomodulatory Gene Targets.

Circulation ◽  
2007 ◽  
Vol 116 (suppl_16) ◽  
Author(s):  
Martin Cadeiras ◽  
Manuel P von Bayern ◽  
Anshu Sinha ◽  
Wei-Keat Lim ◽  
Teresa Palomero ◽  
...  

Background: Reconstruction of intracellular networks underlying complex processes is a formidable challenge. We hypothesized that the human peripheral blood mononuclear cell (PBMC) molecular network can be delineated using a systems-biological/computer-driven approach. Method: We used a large PBMC microarray library, an information-theoretic, reverse-engineering algorithm (ARACNe, Algorithm for the Reconstruction of Accurate Cellular Networks) and Chromatin Immunoprecipitation (ChIP) assay to reconstruct and validate a putative gene interaction network. Results: Gene expression data from 285 focused-microarrays obtained from 98 heart transplant patients enrolled in the Cardiac Allograft Rejection Gene expression Observational (CARGO) study was analyzed by ARACNe to identify highly connected “hub” genes. Biological criteria identified Transcription Factor CREB and its subnetwork as important candidates involved in the regulation of the alloimmune response. ARACNe predicted 29 putative direct interactions (first neighbor genes) of CREB (Fig. 1A ). Eleven of these (Fig. 1A red nodes) were previously reported (p<0.001) and 18 were not (Fig 1A , pink nodes). Out of the non validated, 14 suitable primers were identified and 11 could be immunoprecipitated (Fig 1B ), demonstrating binding of CREB to their promoter in vivo. Overall, 22 (75%) inferred CREB targets were validated; a significantly higher fraction than randomly expected (p<0.001, Fisher’s exact). Conclusion Our results confirm the accuracy of ARACNe to reconstruct the PBMC transcriptional network. Systems biological approaches may be used to identify immunomodulatory pharmacological targets. Figure 1

2018 ◽  
Vol 27 (7) ◽  
pp. 2479-2486 ◽  
Author(s):  
Barbara Bonaparte Ribas de Alcântara ◽  
Felipe Melo Cruz ◽  
Fernando Luiz Affonso Fonseca ◽  
Beatriz da Costa Aguiar Alves ◽  
Matheus Moreira Perez ◽  
...  

2016 ◽  
Vol 25 (1) ◽  
pp. 19-24
Author(s):  
Cicia Firakania ◽  
Indra G. Mansur ◽  
Sri W.A. Jusman ◽  
Mohamad Sadikin

Background: Cell proliferation occurs not only in normal but also in cancer cells. Most of cell proliferation inhibition can be done by inhibiting the DNA synthesis, notably by intervening the formation of purine or pyrimidine. In purine de novo synthesis, it was assumed that biotin plays a role as a coenzyme in carboxylation reaction, one of the pivotal steps in the purine de novo pathways. The aim of this study was to see the avidin potency to bind biotin and inhibit mitosis.Methods: Peripheral blood mononuclear cell (PBMC) was cultured in RPMI-1640 medium and stimulated by phytohemagglutinin (PHA) in the presence or absence of interleukin-2 (IL-2), with or without avidin. The effect of avidin addition was observed at 24, 48, and 72 hours for cell proliferation, viability, and cell cycle. Statistical analysis was done by one-way ANOVA.Results: Avidin inhibited cell proliferation and viability in culture under stimulation by PHA with and without IL-2. Cell cycle analysis showed that avidin arrested the progression of PBMC after 72 hours of culture. Most cells were found in G0/G1 phase.Conclusion: Inhibition of biotin utilization by avidin binding can halt cell proliferation.


Drugs & Aging ◽  
2009 ◽  
Vol 26 (1) ◽  
pp. 87-94 ◽  
Author(s):  
Antonella D’Ambrosio ◽  
Luciana Giordani ◽  
Manuela Colucci ◽  
Nicola Vanacore ◽  
Francesca Quintieri

Sign in / Sign up

Export Citation Format

Share Document